Healthcare provider profile · identity verified

Andrew Edward Keyes, MD

Family Practice · CHATTANOOGA, TN · NPI 1255864229

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	458	133
Amlodipine Besylate	Amlodipine Besylate	314	99
Losartan Potassium	Losartan Potassium	281	96
Levothyroxine Sodium	Levothyroxine Sodium	257	73
Omeprazole	Omeprazole	216	72
Lisinopril	Lisinopril	193	61
Metformin Hcl Er	Metformin Hcl	190	63
Rosuvastatin Calcium	Rosuvastatin Calcium	176	68
Gabapentin	Gabapentin	174	55
Pantoprazole Sodium	Pantoprazole Sodium	166	52
Metoprolol Succinate	Metoprolol Succinate	150	48
Tamsulosin Hcl	Tamsulosin Hcl	150	49
Hydrochlorothiazide	Hydrochlorothiazide	143	46
Albuterol Sulfate Hfa	Albuterol Sulfate	141	44
Montelukast Sodium	Montelukast Sodium	117	37
Sertraline Hcl	Sertraline Hcl	107	29
Fluticasone Propionate	Fluticasone Propionate	103	41
Duloxetine Hcl	Duloxetine Hcl	100	28
Olmesartan Medoxomil	Olmesartan Medoxomil	95	28
Trazodone Hcl	Trazodone Hcl	95	30
Ozempic	Semaglutide	88	23
Famotidine	Famotidine	85	38
Furosemide	Furosemide	81	32
Carvedilol	Carvedilol	76	28
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	75	20
Metoprolol Tartrate	Metoprolol Tartrate	72	27
Clopidogrel	Clopidogrel Bisulfate	71	25
Escitalopram Oxalate	Escitalopram Oxalate	70	17
Clonazepam	Clonazepam	66	suppressed
Eliquis	Apixaban	65	22
Potassium Chloride	Potassium Chloride	65	25
Allopurinol	Allopurinol	63	22
Fluoxetine Hcl	Fluoxetine Hcl	63	17
Tizanidine Hcl	Tizanidine Hcl	62	23
Alprazolam	Alprazolam	61	13
Finasteride	Finasteride	60	18
Chlorthalidone	Chlorthalidone	57	15
Valsartan	Valsartan	57	15
Meloxicam	Meloxicam	55	21
Tramadol Hcl	Tramadol Hcl	53	13
Farxiga	Dapagliflozin Propanediol	49	15
Zolpidem Tartrate	Zolpidem Tartrate	48	13
Glipizide	Glipizide	45	14
Metformin Hcl	Metformin Hcl	42	17
Benazepril Hcl	Benazepril Hcl	41	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	15
Triamcinolone Acetonide	Triamcinolone Acetonide	40	25
Spironolactone	Spironolactone	39	13
Buspirone Hcl	Buspirone Hcl	37	14
Mounjaro	Tirzepatide	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	36	11
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	31	11
Bupropion Xl	Bupropion Hcl	31	suppressed
Xarelto	Rivaroxaban	31	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Jardiance	Empagliflozin	28	12
Estradiol	Estradiol	27	suppressed
Ezetimibe	Ezetimibe	27	11
Atenolol	Atenolol	26	suppressed
Methocarbamol	Methocarbamol	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Bumetanide	Bumetanide	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Varenicline Tartrate	Varenicline Tartrate	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Mometasone Furoate	Mometasone Furoate	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Simvastatin	Simvastatin	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Naproxen	Naproxen	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Irbesartan	Irbesartan	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Primidone	Primidone	18	suppressed
Baclofen	Baclofen	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Topiramate	Topiramate	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Methylprednisolone	Methylprednisolone	16	15
Prednisone	Prednisone	16	13
Celecoxib	Celecoxib	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Azithromycin	Azithromycin	14	14
Lactulose	Lactulose	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Myrbetriq	Mirabegron	12	suppressed
Naratriptan Hcl	Naratriptan Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Torsemide	Torsemide	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Zaleplon	Zaleplon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error